Monsanto Co. (NYSE:MON) is set to release its Q416 earnings data on Wednesday, October 5th. Analysts expect Monsanto to post earnings of ($0.02) per share and revenue of $2.38 billion for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.
Shares of Monsanto Co. (NYSE:MON) opened at 102.20 on Monday. The company’s 50-day moving average price is $105.13 and its 200 day moving average price is $101.01. Monsanto Co. has a 1-year low of $83.73 and a 1-year high of $114.26. The firm has a market cap of $44.72 billion, a PE ratio of 44.98 and a beta of 1.24.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 2.11%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio (DPR) is currently 89.26%.
Several equities research analysts have issued reports on MON shares. TheStreet lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Citigroup Inc. lifted their price target on Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research note on Friday, August 19th. BMO Capital Markets set a $128.00 price target on Monsanto and gave the stock a “buy” rating in a research note on Thursday, September 15th. Credit Agricole SA lowered Monsanto from a “buy” rating to an “underperform” rating and set a $110.00 price target for the company. in a research note on Thursday, September 15th. Finally, Goldman Sachs Group Inc. raised Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 price target for the company in a research note on Tuesday, September 27th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Monsanto has an average rating of “Buy” and a consensus target price of $114.31.
In other news, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.
Institutional investors have recently added to or reduced their stakes in the stock. South Dakota Investment Council purchased a new position in Monsanto during the second quarter valued at $1,551,000. Dorsey & Whitney Trust CO LLC purchased a new position in Monsanto during the second quarter valued at $215,000. Bank of Nova Scotia boosted its position in Monsanto by 6.4% in the second quarter. Bank of Nova Scotia now owns 8,794 shares of the company’s stock valued at $909,000 after buying an additional 530 shares during the last quarter. CNA Financial Corp purchased a new position in Monsanto during the second quarter valued at $714,000. Finally, Trexquant Investment LP boosted its position in Monsanto by 20.4% in the second quarter. Trexquant Investment LP now owns 26,009 shares of the company’s stock valued at $2,690,000 after buying an additional 4,409 shares during the last quarter. 79.06% of the stock is currently owned by hedge funds and other institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.